304 related articles for article (PubMed ID: 2849659)
1. Selective tolerance at mu and kappa opioid receptors modulating norepinephrine release in guinea pig cortex.
Werling LL; McMahon PN; Cox BM
J Pharmacol Exp Ther; 1988 Dec; 247(3):1103-6. PubMed ID: 2849659
[TBL] [Abstract][Full Text] [Related]
2. Effects of prior exposure to morphine on the opioid inhibition of the stimulated release of [3H]norepinephrine from guinea pig cortex slices.
Werling LL; Brown SR; Cox BM
NIDA Res Monogr; 1986; 75():587-90. PubMed ID: 2829006
[TBL] [Abstract][Full Text] [Related]
3. Cross-tolerance between mu- and kappa-opioid agonists in the guinea pig ileum myenteric plexus.
Garaulet JV; Laorden ML; Milanés MV
J Pharmacol Exp Ther; 1994 Jun; 269(3):993-9. PubMed ID: 8014886
[TBL] [Abstract][Full Text] [Related]
4. Differential influence of D1 and D2 dopamine receptors on acute opiate withdrawal in guinea-pig isolated ileum.
Capasso A; Sorrentino L
Br J Pharmacol; 1997 Mar; 120(6):1001-6. PubMed ID: 9134209
[TBL] [Abstract][Full Text] [Related]
5. Cross-tolerance between kappa and mu opioid agonists in the guinea pig ileum myenteric plexus.
Garaulet JV; Milanés MV; Laorden ML
J Pharmacol Exp Ther; 1995 Feb; 272(2):658-62. PubMed ID: 7853179
[TBL] [Abstract][Full Text] [Related]
6. Mu antagonist properties of kappa agonists in a model of rat urinary bladder motility in vivo.
Sheldon RJ; Nunan L; Porreca F
J Pharmacol Exp Ther; 1987 Oct; 243(1):234-40. PubMed ID: 2822899
[TBL] [Abstract][Full Text] [Related]
7. Antidiarrheal properties of supraspinal mu and delta and peripheral mu, delta and kappa opioid receptors: inhibition of diarrhea without constipation.
Shook JE; Lemcke PK; Gehrig CA; Hruby VJ; Burks TF
J Pharmacol Exp Ther; 1989 Apr; 249(1):83-90. PubMed ID: 2540324
[TBL] [Abstract][Full Text] [Related]
8. Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse.
Porreca F; Mosberg HI; Hurst R; Hruby VJ; Burks TF
J Pharmacol Exp Ther; 1984 Aug; 230(2):341-8. PubMed ID: 6086883
[TBL] [Abstract][Full Text] [Related]
9. Involvement of mu, delta and kappa receptors in morphine-induced tolerance in the guinea pig myenteric plexus.
Leedham JA; Bennett LE; Taylor DA; Fleming WW
J Pharmacol Exp Ther; 1991 Oct; 259(1):295-301. PubMed ID: 1656024
[TBL] [Abstract][Full Text] [Related]
10. Peripheral opioid receptors mediating antinociception in inflammation. Evidence for involvement of mu, delta and kappa receptors.
Stein C; Millan MJ; Shippenberg TS; Peter K; Herz A
J Pharmacol Exp Ther; 1989 Mar; 248(3):1269-75. PubMed ID: 2539460
[TBL] [Abstract][Full Text] [Related]
11. Dexamethasone selective inhibition of acute opioid physical dependence in isolated tissues.
Capasso A; Di Giannuario A; Loizzo A; Pieretti S; Sagratella S; Sorrentino L
J Pharmacol Exp Ther; 1996 Feb; 276(2):743-51. PubMed ID: 8632345
[TBL] [Abstract][Full Text] [Related]
12. Multiplicative interaction between intrathecally and intracerebroventricularly administered mu opioid agonists but limited interactions between delta and kappa agonists for antinociception in mice.
Roerig SC; Fujimoto JM
J Pharmacol Exp Ther; 1989 Jun; 249(3):762-8. PubMed ID: 2567350
[TBL] [Abstract][Full Text] [Related]
13. Effect of chronic administration of U-50,488H on tolerance to its pharmacological actions and on multiple opioid receptors in rat brain regions and spinal cord.
Bhargava HN; Gulati A; Ramarao P
J Pharmacol Exp Ther; 1989 Oct; 251(1):21-6. PubMed ID: 2552075
[TBL] [Abstract][Full Text] [Related]
14. Selective and interactive down-regulation of mu- and delta-opioid receptors in human neuroblastoma SK-N-SH cells.
Baumhaker Y; Gafni M; Keren O; Sarne Y
Mol Pharmacol; 1993 Aug; 44(2):461-7. PubMed ID: 8394999
[TBL] [Abstract][Full Text] [Related]
15. Chronic muscle pain induced by repeated acid Injection is reversed by spinally administered mu- and delta-, but not kappa-, opioid receptor agonists.
Sluka KA; Rohlwing JJ; Bussey RA; Eikenberry SA; Wilken JM
J Pharmacol Exp Ther; 2002 Sep; 302(3):1146-50. PubMed ID: 12183674
[TBL] [Abstract][Full Text] [Related]
16. Opioid receptor regulation of the release of norepinephrine in brain.
Werling LL; Brown SR; Cox BM
Neuropharmacology; 1987 Jul; 26(7B):987-96. PubMed ID: 2821438
[TBL] [Abstract][Full Text] [Related]
17. Electrophysiological demonstration of mu, delta and kappa opioid receptors in the ventral pallidum.
Mitrovic I; Napier TC
J Pharmacol Exp Ther; 1995 Mar; 272(3):1260-70. PubMed ID: 7891342
[TBL] [Abstract][Full Text] [Related]
18. Peptide opioid antagonist separates peripheral and central opioid antitransit effects.
Shook JE; Pelton JT; Hruby VJ; Burks TF
J Pharmacol Exp Ther; 1987 Nov; 243(2):492-500. PubMed ID: 2824748
[TBL] [Abstract][Full Text] [Related]
19. Kappa opioid partial agonist activity of the enkephalin-like pentapeptide BW942C based on urination and in vitro studies in humans and animals.
Vaupel DB; Cone EJ; Johnson RE; Su TP
J Pharmacol Exp Ther; 1990 Jan; 252(1):225-34. PubMed ID: 2153801
[TBL] [Abstract][Full Text] [Related]
20. Kappa-opioid receptor-mediated antinociception in the rat. II. Supraspinal in addition to spinal sites of action.
Millan MJ; Członkowski A; Lipkowski A; Herz A
J Pharmacol Exp Ther; 1989 Oct; 251(1):342-50. PubMed ID: 2571723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
